HealthEquity, Inc. provided earning guidance for the fiscal year ending January 31, 2023. For the period, The company expects revenues of $827 million to $837 million. Its outlook for net loss is between $51 million and $43 million resulting in net loss of $0.61 to $0.51 per diluted share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.27 USD | -0.71% | +0.08% | +19.56% |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
May. 14 | HealthEquity Completes Acquisition of Conduent's BenefitWallet | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.56% | 6.9B | |
+14.39% | 3,197B | |
+14.08% | 89.6B | |
+8.04% | 80.08B | |
-12.15% | 55.52B | |
+22.36% | 46.79B | |
+31.67% | 46.34B | |
-29.01% | 43.95B | |
+77.73% | 41.34B | |
-3.95% | 26.5B |
- Stock Market
- Equities
- HQY Stock
- News HealthEquity, Inc.
- HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023